Evaluating the Safety of Ultra-Low-Dose Estrogen Contraception in Sickle Cell Trait With Focus on Cerebral Venous Sinus Thrombosis

Ultra-low-dose combination estrogen-progestin contraceptive pills (OCP) have been marketed as being safer to use than previously higher estrogen-containing OCPs. While multiple large studies have shown a dose-dependent association between estrogen and deep vein thrombosis, there remains sparse guida...

Descripción completa

Detalles Bibliográficos
Autores principales: Kahn, Cameron, Rathore, Azeem, Kronen, Tara, Fahad, Ameen, Crooks, Ryan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2023
Materias:
Internal Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949882/
https://www.ncbi.nlm.nih.gov/pubmed/36843802
http://dx.doi.org/10.7759/cureus.34163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9949882/
https://www.ncbi.nlm.nih.gov/pubmed/36843802
http://dx.doi.org/10.7759/cureus.34163

Ejemplares similares